Crivera C - Search Results

1

Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient Populations.

Shah N, Sussman M, Crivera C, Valluri S, Benner J, Jagannath S. Shah N, et al. Among authors: crivera c. Clin Drug Investig. 2021 Mar;41(3):201-210. doi: 10.1007/s40261-021-01012-x. Epub 2021 Feb 18. Clin Drug Investig. 2021. PMID: 33598857

2

Bayesian data analysis in observational comparative effectiveness research: rationale and examples.

Olson WH, Crivera C, Ma YW, Panish J, Mao L, Lynch SM. Olson WH, et al. Among authors: crivera c. J Comp Eff Res. 2013 Nov;2(6):563-71. doi: 10.2217/cer.13.73. J Comp Eff Res. 2013. PMID: 24236795 Free article.

3

Applying State-of-the-Art Survival Extrapolation Techniques to the Evaluation of CAR-T Therapies: Evidence from a Systematic Literature Review.

Sussman M, Crivera C, Benner J, Adair N. Sussman M, et al. Among authors: crivera c. Adv Ther. 2021 Aug;38(8):4178-4194. doi: 10.1007/s12325-021-01841-4. Epub 2021 Jul 12. Adv Ther. 2021. PMID: 34251651 Free PMC article. Review.

4

Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the US.

Jagannath S, Joseph N, He J, Crivera C, Fu AZ, Garret A, Shah N. Jagannath S, et al. Among authors: crivera c. Oncol Ther. 2021 Dec;9(2):659-669. doi: 10.1007/s40487-021-00175-z. Epub 2021 Oct 25. Oncol Ther. 2021. PMID: 34694578 Free PMC article.

5

Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States.

Jagannath S, Joseph N, He J, Crivera C, Fu AZ, Garrett A, Shah N. Jagannath S, et al. Among authors: crivera c. Oncol Ther. 2022 Dec;10(2):411-420. doi: 10.1007/s40487-022-00198-0. Epub 2022 May 17. Oncol Ther. 2022. PMID: 35579821 Free PMC article.

6

Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma.

Hoda D, Richards R, Faber EA, Deol A, Hunter BD, Weber E, DiFilippo H, Henderson-Clark T, Meaux L, Crivera C, Riccobono C, Garrett A, Jackson CC, Fowler J, Theocharous P, Stewart R, Lorden AL, Porter DL, Berger A. Hoda D, et al. Among authors: crivera c. Future Oncol. 2022 Jun;18(19):2415-2431. doi: 10.2217/fon-2022-0162. Epub 2022 May 18. Future Oncol. 2022. PMID: 35583358

7

Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE-1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma.

Martin T, Krishnan A, Yong K, Weisel K, Mehra M, Nair S, Qi K, Londhe A, Diels J, Crivera C, Jackson CC, Olyslager Y, Vogel M, Schecter JM, Banerjee A, Valluri S, Usmani SZ, Berdeja JG, Jagannath S. Martin T, et al. Among authors: crivera c. EJHaem. 2021 Dec 10;3(1):97-108. doi: 10.1002/jha2.312. eCollection 2022 Feb. EJHaem. 2021. PMID: 35846215 Free PMC article.

8

Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma.

Jagannath S, Joseph N, Crivera C, Kharat A, Jackson CC, Valluri S, Cost P, Phelps H, Slowik R, Klein T, Smolen L, Yu X, Cohen AD. Jagannath S, et al. Among authors: crivera c. Oncol Ther. 2023 Jun;11(2):263-275. doi: 10.1007/s40487-023-00228-5. Epub 2023 Apr 4. Oncol Ther. 2023. PMID: 37014590 Free PMC article.

9

The economic impact of acute coronary syndrome on length of stay: an analysis using the Healthcare Cost and Utilization Project (HCUP) databases.

LaMori JC, Shoheiber O, Dudash K, Crivera C, Mody SH. LaMori JC, et al. Among authors: crivera c. J Med Econ. 2014 Mar;17(3):191-7. doi: 10.3111/13696998.2014.885907. Epub 2014 Feb 7. J Med Econ. 2014. PMID: 24451040 Free article.

10

Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies.

Kohn CG, Fermann GJ, Peacock WF, Wells PS, Baugh CW, Ashton V, Crivera C, Schein JR, Wildgoose P, Coleman CI. Kohn CG, et al. Among authors: crivera c. Curr Med Res Opin. 2017 Sep;33(9):1697-1703. doi: 10.1080/03007995.2017.1349659. Epub 2017 Jul 17. Curr Med Res Opin. 2017. PMID: 28665208 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page